Cardiac magnetic resonance assessment of right ventricular remodeling after anthracycline therapy

Abstract There are limited data on the effects of anthracyclines on right ventricular (RV) structure, function, and tissue characteristics. The goal of this study was to investigate the effects of anthracyclines on the RV using cardiac magnetic resonance (CMR). This was a post-hoc analysis of a pros...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Thiago Ferreira de Souza, Thiago Quinaglia Silva, Lígia Antunes-Correa, Zsofia D. Drobni, Felipe Osório Costa, Sergio San Juan Dertkigil, Wilson Nadruz, Fabrício Brenelli, Andrei C. Sposito, José Roberto Matos-Souza, Otávio Rizzi Coelho, Tomas G. Neilan, Michael Jerosch-Herold, Otávio Rizzi Coelho-Filho
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/86f331c601744a65ba8265c0d625b14e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:86f331c601744a65ba8265c0d625b14e
record_format dspace
spelling oai:doaj.org-article:86f331c601744a65ba8265c0d625b14e2021-12-02T16:35:05ZCardiac magnetic resonance assessment of right ventricular remodeling after anthracycline therapy10.1038/s41598-021-96630-y2045-2322https://doaj.org/article/86f331c601744a65ba8265c0d625b14e2021-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-96630-yhttps://doaj.org/toc/2045-2322Abstract There are limited data on the effects of anthracyclines on right ventricular (RV) structure, function, and tissue characteristics. The goal of this study was to investigate the effects of anthracyclines on the RV using cardiac magnetic resonance (CMR). This was a post-hoc analysis of a prospective study of 27 breast cancer (BC) patients (51.8 ± 8.9 years) using CMR prior, and up to 3-times after anthracyclines (240 mg/m2) to measure RV volumes and mass, RV extracellular volume (ECV) and cardiomyocyte mass (CM). Before anthracyclines, LVEF (69.4 ± 3.6%) and RVEF (55.6 ± 9%) were normal. The median follow-up after anthracyclines was 399 days (IQR 310–517). The RVEF reached its nadir (46.3 ± 6.8%) after 9-months (P < 0.001). RV mass-index and RV CM decreased to 13 ± 2.8 g/m2 and 8.13 ± 2 g/m2, respectively, at 16-months after anthracyclines. The RV ECV expanded from 0.26 ± 0.07 by 0.14 (53%) to 0.40 ± 0.1 (P < 0.001). The RV ECV expansion correlated with a decrease in RV mass-index (r = −0.46; P < 0.001) and the increase in CK-MB. An RV ESV index at baseline above its median predicted an increased risk of LV dysfunction post-anthracyclines. In BC patients treated with anthracyclines, RV atrophy, systolic dysfunction, and a parallel increase of diffuse interstitial fibrosis indicate a cardiotoxic response on a similar scale as previously seen in the systemic left ventricle.Thiago Ferreira de SouzaThiago Quinaglia SilvaLígia Antunes-CorreaZsofia D. DrobniFelipe Osório CostaSergio San Juan DertkigilWilson NadruzFabrício BrenelliAndrei C. SpositoJosé Roberto Matos-SouzaOtávio Rizzi CoelhoTomas G. NeilanMichael Jerosch-HeroldOtávio Rizzi Coelho-FilhoNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Thiago Ferreira de Souza
Thiago Quinaglia Silva
Lígia Antunes-Correa
Zsofia D. Drobni
Felipe Osório Costa
Sergio San Juan Dertkigil
Wilson Nadruz
Fabrício Brenelli
Andrei C. Sposito
José Roberto Matos-Souza
Otávio Rizzi Coelho
Tomas G. Neilan
Michael Jerosch-Herold
Otávio Rizzi Coelho-Filho
Cardiac magnetic resonance assessment of right ventricular remodeling after anthracycline therapy
description Abstract There are limited data on the effects of anthracyclines on right ventricular (RV) structure, function, and tissue characteristics. The goal of this study was to investigate the effects of anthracyclines on the RV using cardiac magnetic resonance (CMR). This was a post-hoc analysis of a prospective study of 27 breast cancer (BC) patients (51.8 ± 8.9 years) using CMR prior, and up to 3-times after anthracyclines (240 mg/m2) to measure RV volumes and mass, RV extracellular volume (ECV) and cardiomyocyte mass (CM). Before anthracyclines, LVEF (69.4 ± 3.6%) and RVEF (55.6 ± 9%) were normal. The median follow-up after anthracyclines was 399 days (IQR 310–517). The RVEF reached its nadir (46.3 ± 6.8%) after 9-months (P < 0.001). RV mass-index and RV CM decreased to 13 ± 2.8 g/m2 and 8.13 ± 2 g/m2, respectively, at 16-months after anthracyclines. The RV ECV expanded from 0.26 ± 0.07 by 0.14 (53%) to 0.40 ± 0.1 (P < 0.001). The RV ECV expansion correlated with a decrease in RV mass-index (r = −0.46; P < 0.001) and the increase in CK-MB. An RV ESV index at baseline above its median predicted an increased risk of LV dysfunction post-anthracyclines. In BC patients treated with anthracyclines, RV atrophy, systolic dysfunction, and a parallel increase of diffuse interstitial fibrosis indicate a cardiotoxic response on a similar scale as previously seen in the systemic left ventricle.
format article
author Thiago Ferreira de Souza
Thiago Quinaglia Silva
Lígia Antunes-Correa
Zsofia D. Drobni
Felipe Osório Costa
Sergio San Juan Dertkigil
Wilson Nadruz
Fabrício Brenelli
Andrei C. Sposito
José Roberto Matos-Souza
Otávio Rizzi Coelho
Tomas G. Neilan
Michael Jerosch-Herold
Otávio Rizzi Coelho-Filho
author_facet Thiago Ferreira de Souza
Thiago Quinaglia Silva
Lígia Antunes-Correa
Zsofia D. Drobni
Felipe Osório Costa
Sergio San Juan Dertkigil
Wilson Nadruz
Fabrício Brenelli
Andrei C. Sposito
José Roberto Matos-Souza
Otávio Rizzi Coelho
Tomas G. Neilan
Michael Jerosch-Herold
Otávio Rizzi Coelho-Filho
author_sort Thiago Ferreira de Souza
title Cardiac magnetic resonance assessment of right ventricular remodeling after anthracycline therapy
title_short Cardiac magnetic resonance assessment of right ventricular remodeling after anthracycline therapy
title_full Cardiac magnetic resonance assessment of right ventricular remodeling after anthracycline therapy
title_fullStr Cardiac magnetic resonance assessment of right ventricular remodeling after anthracycline therapy
title_full_unstemmed Cardiac magnetic resonance assessment of right ventricular remodeling after anthracycline therapy
title_sort cardiac magnetic resonance assessment of right ventricular remodeling after anthracycline therapy
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/86f331c601744a65ba8265c0d625b14e
work_keys_str_mv AT thiagoferreiradesouza cardiacmagneticresonanceassessmentofrightventricularremodelingafteranthracyclinetherapy
AT thiagoquinagliasilva cardiacmagneticresonanceassessmentofrightventricularremodelingafteranthracyclinetherapy
AT ligiaantunescorrea cardiacmagneticresonanceassessmentofrightventricularremodelingafteranthracyclinetherapy
AT zsofiaddrobni cardiacmagneticresonanceassessmentofrightventricularremodelingafteranthracyclinetherapy
AT felipeosoriocosta cardiacmagneticresonanceassessmentofrightventricularremodelingafteranthracyclinetherapy
AT sergiosanjuandertkigil cardiacmagneticresonanceassessmentofrightventricularremodelingafteranthracyclinetherapy
AT wilsonnadruz cardiacmagneticresonanceassessmentofrightventricularremodelingafteranthracyclinetherapy
AT fabriciobrenelli cardiacmagneticresonanceassessmentofrightventricularremodelingafteranthracyclinetherapy
AT andreicsposito cardiacmagneticresonanceassessmentofrightventricularremodelingafteranthracyclinetherapy
AT joserobertomatossouza cardiacmagneticresonanceassessmentofrightventricularremodelingafteranthracyclinetherapy
AT otaviorizzicoelho cardiacmagneticresonanceassessmentofrightventricularremodelingafteranthracyclinetherapy
AT tomasgneilan cardiacmagneticresonanceassessmentofrightventricularremodelingafteranthracyclinetherapy
AT michaeljeroschherold cardiacmagneticresonanceassessmentofrightventricularremodelingafteranthracyclinetherapy
AT otaviorizzicoelhofilho cardiacmagneticresonanceassessmentofrightventricularremodelingafteranthracyclinetherapy
_version_ 1718383766272999424